PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
ANGPT2 105 Target Disease Heart Disease 118,291 1 0.00 -1.00 0.01 0.54
ANGPT2 105 Target Disease Contraception 21,402 1 0.00 -1.00 0.01 0.58
ANGPT2 105 Target Disease Infertility 35,448 1 0.00 -1.00 0.01 0.57
ANGPT1 81 Target Target EPHB4 329 1 0.01 -0.99 0.01 0.71
ANGPT1 81 Target Target CCL5 2,002 1 0.00 -0.99 0.01 0.65
ANGPT1 81 Target Disease Osteoporosis 46,215 1 0.00 -0.99 0.01 0.57
ANGPT1 81 Target Target ERK1 18,374 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Target Phospholipase A2 13,400 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Disease Renal Failure 73,993 1 0.00 -0.99 0.01 0.56
ANGPT1 81 Target Disease Arthritis 128,324 1 0.00 -0.99 0.01 0.54
ANGPT1 81 Target Disease Diabetic Nephropathy 12,496 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Disease Benign Prostatic Hyperplasia 10,026 1 0.00 -0.99 0.01 0.60
ANGPT1 81 Target Target CCL2 3,560 1 0.00 -0.99 0.01 0.63
ANGPT1 81 Target Target EPHB2 385 1 0.01 -0.99 0.01 0.70
ANGPT1 81 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.99 0.01 0.55
ANGPT1 81 Target Disease Dyslipidemia 15,225 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Target Renin 43,456 1 0.00 -0.99 0.01 0.57
ANGPT1 81 Target Disease Sepsis 64,798 1 0.00 -0.99 0.01 0.56
ANGPT1 81 Target Target BMPR1A 279 1 0.01 -0.99 0.01 0.71
ANGPT1 81 Target Disease Leukemia 162,805 1 0.00 -0.99 0.01 0.54
ANGPT1 81 Target Target Endoglin 1,333 1 0.00 -0.99 0.01 0.66
ANGPT1 81 Target Disease Hyperlipidemia 15,317 1 0.00 -0.99 0.01 0.59
ANGPT1 81 Target Target BMP-2 3,889 1 0.00 -0.99 0.01 0.63
ANGPT1 81 Target Disease Glioblastoma 17,933 1 0.00 -0.99 0.01 0.59
AMY2B 21 Target Target APOA2 118 1 0.02 -0.97 0.05 0.76
AMY2B 21 Target Disease Scoliosis 14,102 1 0.00 -0.98 0.05 0.62
AMY2B 21 Target Disease Psoriasis 26,882 1 0.00 -0.98 0.05 0.60
AMBP 160 Target Target Angiotensin Converting Enzyme 31,674 1 0.00 -1.00 0.01 0.56
AMBP 160 Target Disease Back Pain 30,003 1 0.00 -1.00 0.01 0.56
AMBP 160 Target Disease Arrhythmia 29,330 1 0.00 -1.00 0.01 0.56
AMBP 160 Target Disease Diabetes Mellitus Type 2 1,311 1 0.00 -1.00 0.01 0.65
AMBP 160 Target Disease Tuberculosis 146,217 1 0.00 -1.00 0.01 0.53
AMBP 160 Target Disease Bladder Cancer 21,509 1 0.00 -1.00 0.01 0.57
AMBP 160 Target Target B2M 677 1 0.00 -1.00 0.01 0.67
AMBP 160 Target Disease Glomerulonephritis 23,459 1 0.00 -1.00 0.01 0.57
AMBP 160 Target Target ERK1 18,374 1 0.00 -1.00 0.01 0.58
AMBP 160 Target Target AFP 9,751 1 0.00 -1.00 0.01 0.59
AMBP 160 Target Target Adiponectin 11,994 1 0.00 -1.00 0.01 0.59
AMBP 160 Target Target A1AT 329 1 0.00 -1.00 0.01 0.70
AMBP 160 Target Disease Anemia 81,663 1 0.00 -1.00 0.01 0.54
AMBP 160 Target Target APOA1 958 1 0.00 -1.00 0.01 0.66
AMBP 160 Target Disease Major Depressive Disorder 12,517 1 0.00 -1.00 0.01 0.59
AMBP 160 Target Disease Headache 50,687 1 0.00 -1.00 0.01 0.55
AMBP 160 Target Target Alpha-Amylase 7,171 1 0.00 -1.00 0.01 0.60
AMBP 160 Target Target Kallikrein-6 79 1 0.01 -0.99 0.01 0.73
AMBP 160 Target Target Collagen 138,882 1 0.00 -1.00 0.01 0.53
AMBP 160 Target Target AHSG 176 1 0.01 -0.99 0.01 0.72
AMBP 160 Target Disease Diabetic Retinopathy 14,494 1 0.00 -1.00 0.01 0.58
AMBP 160 Target Disease Pain 409,851 1 0.00 -1.00 0.01 0.51
AMBP 160 Target Disease Leukemia 162,805 1 0.00 -1.00 0.01 0.53
AMBP 160 Target Disease Hyperlipidemia 15,317 1 0.00 -1.00 0.01 0.58
AMBP 160 Target Disease Lung Cancer 91,416 1 0.00 -1.00 0.01 0.54
AMBP 160 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.01 0.55
AMBP 160 Target Disease Vertigo 10,084 1 0.00 -1.00 0.01 0.59
AMAC-1 19 Target Disease Osteoarthritis 36,287 1 0.00 -0.97 0.05 0.60
AMAC-1 19 Target Disease Cancer 1,053,491 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target CCL4 5,638 1 0.00 -0.97 0.05 0.64
AMAC-1 19 Target Target CD14 9,941 1 0.00 -0.97 0.05 0.63
AMAC-1 19 Target Disease Infection 766,637 1 0.00 -0.97 0.05 0.53
AMAC-1 19 Target Target Eotaxin 2,457 1 0.00 -0.97 0.05 0.66
AMAC-1 19 Target Disease Arthritis 128,324 1 0.00 -0.97 0.05 0.57
AMAC-1 19 Target Target CCL2 3,560 1 0.00 -0.97 0.05 0.65
AMAC-1 19 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -0.97 0.05 0.58
AMAC-1 19 Target Target CCL3 1,427 1 0.01 -0.97 0.05 0.68
AMAC-1 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
AMAC-1 19 Target Disease Septic Arthritis 4,121 1 0.00 -0.97 0.05 0.65
ALPP 80 Target Disease Menopause 19,680 1 0.00 -0.99 0.01 0.59
ALPP 80 Target Disease Disabilities 28,757 1 0.00 -0.99 0.01 0.58
ALPP 80 Target Disease Infertility 35,448 1 0.00 -0.99 0.01 0.57
ALK Phos 19 Target Target CD146 729 1 0.01 -0.97 0.05 0.70
ALK Phos 19 Target Target Collagen 138,882 1 0.00 -0.97 0.05 0.57
ALK Phos 19 Target Disease Hepatitis 163,842 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Pain 409,851 1 0.00 -0.97 0.05 0.54
ALK Phos 19 Target Disease Breast Cancer 173,695 1 0.00 -0.97 0.05 0.56
ALK Phos 19 Target Disease Skin Rash 3,684 1 0.00 -0.97 0.05 0.65
ALK Phos 19 Target Disease Inflammation 252,734 1 0.00 -0.97 0.05 0.55
ALK Phos 19 Target Disease Liver Disease 49,817 1 0.00 -0.97 0.05 0.59
AKT3 293 Target Disease Multiple Myeloma 24,594 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Target ANGPTL4 289 1 0.00 -1.00 0.00 0.69
AKT3 293 Target Target ETS1 539 1 0.00 -1.00 0.00 0.67
AKT3 293 Target Disease Arthritis 128,324 1 0.00 -1.00 0.00 0.52
AKT3 293 Target Target CCL2 3,560 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target Urokinase-Type Plasminogen Activator 3,939 1 0.00 -1.00 0.00 0.61
AKT3 293 Target Target APOE 12,771 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Disease Sarcoidosis 19,176 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Salivary Gland Cancer 202 1 0.00 -1.00 0.00 0.70
AKT3 293 Target Disease Rheumatoid Arthritis 78,952 1 0.00 -1.00 0.00 0.53
AKT3 293 Target Disease Cholesterol 182,390 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Disease Hepatitis 163,842 1 0.00 -1.00 0.00 0.51
AKT3 293 Target Target Cox-2 21,583 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Autism 20,962 1 0.00 -1.00 0.00 0.56
AKT3 293 Target Disease Pain 409,851 1 0.00 -1.00 0.00 0.50
AKT3 293 Target Target bFGF 9,327 1 0.00 -1.00 0.00 0.58
AKT3 293 Target Disease Brain Tumors 16,749 1 0.00 -1.00 0.00 0.57
AKT3 293 Target Target Glutathione S-Transferase Mu 2 8 1 0.02 -0.93 0.12 0.74
AKT3 293 Target Disease Liver Disease 49,817 1 0.00 -1.00 0.00 0.54
AKT3 293 Target Disease Mesothelioma 11,198 1 0.00 -1.00 0.00 0.58
AKT2 873 Target Target Calmodulin 25,240 1 0.00 -1.00 0.00 0.53
AKT2 873 Target Disease Back Pain 30,003 1 0.00 -1.00 0.00 0.53
AKT2 873 Target Disease Fracture 111,575 1 0.00 -1.00 0.00 0.50